<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00897975</url>
  </required_header>
  <id_info>
    <org_study_id>FWA00005390 Chestnut HillHC</org_study_id>
    <nct_id>NCT00897975</nct_id>
  </id_info>
  <brief_title>Red Yeast Rice and Phytosterols In Statin Intolerance</brief_title>
  <official_title>Red Yeast Rice and Phytosterols Versus Red Yeast Rice and Placebo for the Treatment of Hyperlipidemia in Patients With Statin Intolerance: A Multi-Center Randomized Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chestnut Hill Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chestnut Hill Health System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Red yeast rice may be useful to lower cholesterol, especially in a population of patients who&#xD;
      cannot tolerate traditional therapy with statins.&#xD;
&#xD;
      The addition of an over-the-counter phytosterol to red yeast rice may offer additional lipid&#xD;
      lowering benefits when compared to red yeast rice alone.&#xD;
&#xD;
      These supplements will be given to all participants. Up to one-half will enroll in a&#xD;
      lifestyle intervention program called Change of Heart and will be compared to patients who do&#xD;
      not participate in the program. The study will last one year.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although recent studies have shown that red yeast rice is an effective therapy in the&#xD;
      treatment of hyperlipidemia, additional supplements may be required to lower cholesterol to&#xD;
      levels that have been associated with decreased coronary events. Specifically a target has&#xD;
      been to lower low-density lipoprotein-C (LDL-C) to levels below 100 mg/dl. Red yeast rice has&#xD;
      been found to be effective in lowering cholesterol in the context of the Change of Heart&#xD;
      Program, where participants are encouraged to make significant lifestyle changes. This has&#xD;
      been documented in two recent trials that we have published in the past year in the Mayo&#xD;
      Clinic Proceedings (July 2008) and The Annals of Internal Medicine (in press). Clinically, we&#xD;
      have found it necessary to add a phytosterol supplement to red yeast rice to lower LDL-C&#xD;
      levels below 100 mg/dl. There has been a great deal of interest in phytosterols in both the&#xD;
      lay and medical press in the past several years. This over the counter supplement lowers&#xD;
      cholesterol by acting in the intestine to decrease the absorption of cholesterol. As it is&#xD;
      not absorbed, there have not been any reports of significant side effects. The purpose of&#xD;
      this study is to examine the lipid lowering effects of red yeast rice with and without adding&#xD;
      a phytosterol. Some participants will attend the Change of Heart Program and take these&#xD;
      supplements. Another group of participants will take the same supplements, with their usual&#xD;
      medical care, but not enroll in the Change of Heart Program. The study will last one year,&#xD;
      and participants will have been intolerant of statins in the past.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL cholesterol levels</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>myalgia compared to prior statin usage</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>other lipoprotein levels</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight loss in TLC program vs. baseline</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>red yeast rice (RYR) plus phytosterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>arm will take red yeast rice and phytosterol supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>red yeast rice plus placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TLC plus red yeast rice plus placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects attend 12 week therapeutic lifestyle program and take above supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TLC plus RYR plus phytosterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Therapeutic lifestyle program for 12 weeks plus red yeast rice plus phytosterol</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>red yeast rice</intervention_name>
    <description>600 mg 3 capsules bid</description>
    <arm_group_label>TLC plus RYR plus phytosterol</arm_group_label>
    <arm_group_label>TLC plus red yeast rice plus placebo</arm_group_label>
    <arm_group_label>red yeast rice (RYR) plus phytosterol</arm_group_label>
    <arm_group_label>red yeast rice plus placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>phytosterol</intervention_name>
    <description>phytosterol 450 mg 2 tabs bid with food</description>
    <arm_group_label>TLC plus RYR plus phytosterol</arm_group_label>
    <arm_group_label>red yeast rice (RYR) plus phytosterol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>therapeutic lifestyle program</intervention_name>
    <description>TLC - 12 weeks</description>
    <arm_group_label>TLC plus RYR plus phytosterol</arm_group_label>
    <arm_group_label>TLC plus red yeast rice plus placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>TLC plus red yeast rice plus placebo</arm_group_label>
    <arm_group_label>red yeast rice plus placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women age &gt; 21&#xD;
&#xD;
          -  LDL &gt; 100 and physician suggestion to take statin&#xD;
&#xD;
          -  Subject complains of muscle weakness or aching which he/she or his/her physician feels&#xD;
             may be attributable to statin therapy&#xD;
&#xD;
          -  Having stopped a statin drug for personal reasons and not willing to restart this&#xD;
             medication&#xD;
&#xD;
          -  Refusal to take a statin as prescribed by personal physician&#xD;
&#xD;
          -  CPK &lt; 400&#xD;
&#xD;
          -  Not taking any cholesterol lowering medication, red yeast rice extract or a&#xD;
             phytosterol product for at least 1 month prior to initiation of trial&#xD;
&#xD;
          -  Ability to exercise without physical restrictions&#xD;
&#xD;
          -  Ability to attend 12 week consecutive Change of Heart lifestyle education sessions&#xD;
&#xD;
          -  Liver function studies normal at baseline&#xD;
&#xD;
          -  Subject willing to remain off the dietary supplement CoQ10 for duration of trial&#xD;
&#xD;
          -  TSH must be normal&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A history of muscle damage (CPK &gt; 400 IU) on statin therapy&#xD;
&#xD;
          -  Any active cardiac problem including chest pain, angina, shortness of breath with&#xD;
             minimal activity, or unstable angina/acute coronary syndrome within one year&#xD;
&#xD;
          -  Known intolerance to one of the study drugs&#xD;
&#xD;
          -  Physical limitation preventing aerobic exercise program, such as severe arthritis,&#xD;
             peripheral vascular disease, congestive heart failure, or symptom limiting pulmonary&#xD;
             disease&#xD;
&#xD;
          -  Uncontrolled hypertension (defined as SBP &gt; 180 mmHg or DBP &gt; 100 mmHg&#xD;
&#xD;
          -  Heart attack, bypass surgery, or angioplasty/stent within 1 year of study&#xD;
&#xD;
          -  Triglyceride level more than 400 mg/dl&#xD;
&#xD;
          -  Underlying musculoskeletal disorder preventing muscle testing&#xD;
&#xD;
          -  Taking other medicines including: cyclosporine, erythromycin or other macrolide&#xD;
             antibiotics; fluconazole; niacin; fibrates; or &gt; 16 oz. of grapefruit juice daily&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Becker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chestnut Hill Heathcare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chestnut Hill Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>May 11, 2009</study_first_submitted>
  <study_first_submitted_qc>May 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2009</study_first_posted>
  <last_update_submitted>July 14, 2011</last_update_submitted>
  <last_update_submitted_qc>July 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>David Becker, MD</name_title>
    <organization>Chestnut Hill Hospital</organization>
  </responsible_party>
  <keyword>statin associated myalgias</keyword>
  <keyword>hyperlipidemia</keyword>
  <keyword>red yeast rice</keyword>
  <keyword>phytosterols</keyword>
  <keyword>therapeutic lifestyle changes</keyword>
  <keyword>compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Red yeast rice</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 15, 2014</submitted>
    <returned>March 31, 2014</returned>
    <submitted>November 10, 2014</submitted>
    <returned>November 18, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

